
Cubismi is a physician-led grassroots AI-cloud company using human-centered design processes to build a first DecisionFlow-3D™ platform for clinical medicine — to deliver novel decision augmentation and decision intelligence experiences that will enable physicians to drive personalization of each patient’s care pathway. For cancer patients, the platform will deliver critical-need “street views” of tumor heterogeneity for better treatment selection and the potential for far more sensitive detection of early cancer. The platform leverages a cutting-edge “data fabric” informatics technology to anatomically structure data from a potentially unlimited array including medical imaging and all other health data.

Cubismi is a physician-led grassroots AI-cloud company using human-centered design processes to build a first DecisionFlow-3D™ platform for clinical medicine — to deliver novel decision augmentation and decision intelligence experiences that will enable physicians to drive personalization of each patient’s care pathway. For cancer patients, the platform will deliver critical-need “street views” of tumor heterogeneity for better treatment selection and the potential for far more sensitive detection of early cancer. The platform leverages a cutting-edge “data fabric” informatics technology to anatomically structure data from a potentially unlimited array including medical imaging and all other health data.
Founded: 2016
Headquarters: Chevy Chase, MD (Washington, DC metro)
Product: Connexus DecisionFlow-3D platform (multimodal AI cloud data fabric)
Stage / Funding rounds: Seed round announced Apr 12, 2018
Founder (listed): Moira Schieke
Clinical decision support and personalized medicine, with applications in oncology imaging and multimodal health data integration.
2016
Healthcare / Healthtech
One disclosed funding round listed as a Seed round announced Apr 12, 2018; amount obfuscated in available records.